Fusion Antibodies plc (FAB.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 14.41M |
| Enterprise Value | 13.7M |
| P/E Ratio | -11.62 |
| PEG Ratio | -0.14 |
| Price/Sales Ratio | 6.82 |
| Price/Book Ratio | 8.36 |
| Enterprise/Revenue | 6.48 |
| Enterprise/EBITDA | -9.08 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.54 |
| Operating Margin | -0.95 |
AD
Management Effectiveness
| Return On Assets | -0.42 |
| Return On Equity | -0.98 |
Income Statement
| Revenue | 2.11M |
| Revenue/Share | 0.02 |
| Gross Profit | 1.1M |
| EBITDA | -1.85M |
| Net Income | -1.15M |
| Diluted EPS | -0.01 |
Balance Sheet
| Total Cash | 1.04M |
| Total Cash/Share | 0.01 |
| Total Debt | 331,000 |
| Total Debt/Equity | 0.2 |
| Current Ratio | 2.82 |
| Book Value Per Share | 0.01 |
Price History
| 52-Week Change | -32.35 |
| 52-Week High | 20 |
| 52-Week Low | 9 |
| Moving Average 50 Days | 10.97 |
| Moving Average 200 Days | 12.67 |
Statistics
| Average Volume | 358,409 |
| Shares Outstanding | 125.16M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
